Speaker

Ethan Lazarus, MD

Speaker

Lisa Walden

Description

Each generation ushers in a unique perspective on how we work and live. Whether it’s embracing daily usage of emojis, asking for efficiency in meetings, establishing clarity through hierarchy, or demanding diverse representation, every generational cohort leaves a distinct mark. These differences in perspective are wonderful and enriching, but can also cause frustration and disconnection when not properly understood. 
 
In this presentation, Lisa brings some clarity to the generational conversation, providing an extra lens for you to better connect with those you interact with every day. She’ll break down the heart of generational theory, bust some common stereotypes, and generate awareness for why each generation behaves the way they do. Armed with the power of generational understanding, you can venture into the work world work with the tools you need to improve connection and build stronger relationships with colleagues and patients alike. 

Learning Objectives

1. Decrypting every generation’s formative years, and how those experiences inform distinct generational identities 
2. Identify the potential areas for disconnect across generations, and how to overcome those barriers and build stronger relationships 
3. Explore how the newest generation, Gen Z, will shake up how we work, communicate, and connect 

Speaker

Alicia Shelly, MD, FACP

Description

This session will discuss the prevalence and etiologies of weight regain after bariatric surgery. It will also discuss current available treatments for managing Weight Regain after bariatric surgery.  This interactive session will utilize case-based learning to explore best practices for treatment of weight regain after bariatric surgery.

Learning Objectives

1. Define weight regain and discuss the prevalence of weight regain after bariatric surgery. 
2. Manage patients who suffer with weight regain after bariatric surgery. 
3. Describe the causes of weight regain after bariatric surgery. 

Speakers

Elizabeth Mills, PharmD, BCACP, CDCES

Katie Trotta, PharmD, BCACP

Description

A core component of obesity treatment includes recognition of weight promoting medications and their alternatives.  Transitioning off of weight promoting medications onto weight friendly alternative is another challenge. This session will identify commonly used medications that are known to promote weight gain and the benefits of their more favorable substitutes. The program will explore key considerations for safe transition off of weight positive medications along with strategies to prevent unintended complications from medication withdrawal.

Learning Objectives

1. Identify commonly use medications that promote weight gain 
2. List suitable alternatives to weight promoting medications 
3. Utilize strategies for the safe transition off of weight promoting medications and on to weight favorable alternatives 

Speaker

Donna Ryan, MD, MABOM, FTOS

Description

Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning. There is a rich pipeline of future anti-obesity medications (AOM) that will give provides excellent options for both the treatment of obesity and of the obesity-related diseases. This session will start with reviewing some of the common pathophysiologic pathways that current and future AOM’s target then discuss emerging and future prospects of pharmacotherapy for the treatment of obesity.

Learning Objectives

1. Identify pathophysiologic pathways targeted to treat obesity 
2. Discuss emerging therapies for the medical treatment of obesity 
3. Describe some novel obesity treatments under investigation 
4. Discuss the role cardiovascular outcomes may play in the evaluation of AOM’s 

Speakers

Katie Trotta, PharmD, BCACP

Elizabeth Mills, PharmD, BCACP, CDCES

Donna Ryan, MD, MABOM, FTOS

Learning Objectives

1. Discuss key takeaways from the pharmacology lectures 
2. Ask specific questions about managing obesity with the use of pharmacology in a Q&A panel with faculty experts. 

Speaker

John Jakicic, PhD

Description

Physical activity is considered an important component of obesity treatment; however, the effect of physical activity on weight can be variable. Moreover, the dose, intensity, and mode of physical activity may contribute to the weight loss response. This session will explore these factors related to the effects of physical activity on weight loss and with weight maintenance.   

Learning Objectives

1. Describe the effects of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity.
2. Describe the effects of different volumes and intensities of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity.  
3. Describe the effects of different modes of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity. 

Speakers

John Jakicic, PhD

Carl Knopke MD, FOMA, FAAFP

Karli Burridge PA-C, MMS, FOMA

Description

Knowledge is good, skills are better. This session will focus on applying physical activity programs in the treatment of obesity. The cases will involve developing an activity plan with a patient, tracking progress, and overcoming challenges to maintaining an activity plan.

Learning Objectives

1. Develop a patient-centered activity plan
2. Utilize tools to track physical activity progress and outcomes 
3. Analyze and strategize ways to help overcome activity limitations 

Speakers

John Jakicic, PhD

Carl Knopke MD, FOMA, FAAFP

Karli Burridge PA-C, MMS, FOMA

Learning Objectives

1. Discuss key takeaways from the physical activity lectures
2. Ask specific questions about managing obesity with the use of physical activity in a Q&A panel with faculty experts. 

Friday, Oct. 14 | 7:00 – 10:00pm | The Fifth Rooftop

Cost: $25 for Members, $50 per Member Guest

OMA members get the chance to celebrate with fellow obesity medicine specialists at The Fifth Rooftop in Anaheim. Come relax at the 5,000 square foot open air rooftop. Help us recognize OMA’s leaders’ accomplishments and incoming board members. Join us for delicious food, craft cocktails, stunning sunset views, firepits, music, and more. Also, experience Disney fireworks after dark!

*Member event only. Limited capacity. Registration required as add-on to conference registration.

Description

This is a great opportunity to explore a topic of interest with an obesity medicine specialist with expertise in the field. These are small-group sessions that allow for engaging conversation. Choose a table with a topic that interests you and spend breakfast discussing that topic with an expert and a few other colleagues. 

*This event is worth an optional 0.75 CME/CE credits. Attendance is not required to earn the full 17.5 CME/CE credits for the Fall Obesity Summit. 

Speaker

Robert Lustig, MD, MSL

Learning Objectives

1. Recognize the importance of liver fat in chronic disease
2. Describe the role of mitochondria in liver fat  
3. Discuss the role of fructose in mitochondrial dysfunction  
4. Utilize lifestyle strategies to protect liver function 

Speakers

Sandra Christensen MSN, ARNP, FNP-BC, FOMA

Lori Wenz, NP-C, BC-ADM

Description

Obesity medicine clinicians routinely have challenging conversations with patients. Many patients have emotionally charged histories about their weight and health. Previous encounters with biased clinicians influence a patient’s willingness to trust the clinician and engage in treatment. 
In this presentation, the presenters will demonstrate real-life clinical conversations that utilize a coaching mindset and incorporate the concepts of Motivational Interviewing and the 5 As of obesity counseling. We will go beyond theories and demonstrate examples of what works. Because telling a patient what to do or how to feel rarely works, clinicians will learn how to structure the conversation in a manner that establishes and maintains trust in the therapeutic relationship, elicits the patient’s motivation to change, and leads to improved health behaviors. 

Learning Objectives

1. Recognize the importance of establishing and maintaining trust in the therapeutic relationship
2. Describe the theoretical frameworks of Motivational Interviewing, the 5 As of obesity counseling, and health coaching
3. Integrate the concepts of Motivational Interviewing, the 5 As of obesity counseling, and health coaching into common, real-life clinical conversations 

Speaker

Angela Golden, DNP, FNP-C, FAANP

Description

Many practices do not have nutritional professionals to assist their patients make eating plan selections. Providers are called upon to help the patients with this important pillar of care. This presentation will review the current evidence for nutrition treatment in obesity including meal patterns and eating plans. Using case studies the presentation will provide examples of shared decision-making for goal setting to help patients move to using food as part of their successful obesity treatment plan.

Learning Objectives

1. Evaluate current evidence for diets and meal patterns for the treatment of obesity
2. List the advantages for each eating plan based on patient's lifestyle and ORCs 
3. Analyze food logs to provide guidance to a patient 

Speakers

Sandra Christensen, MSN, ARNP, FNP-BC, FOMA

Lori Wenz, NP-C, BC-ADM

Angela Golden, DNP, FNP-C, FAANP

Learning Objectives

1. Discuss key takeaways from the behavior lectures
2. Ask specific questions about managing obesity with behavior modification in a Q&A panel with faculty experts. 

Speaker

Andres Acosta, MD

Description

Obesity is a chronic, relapsing, and multifactorial disease with significant individual variability in response to therapeutic interventions. This session will discuss the heterogeneity of human obesity and identifying predictors of response to weight loss interventions. Specifically, we identified four potential pathophysiologic and behavioral obesity phenotypes: abnormal satiation, abnormal postprandial satiety, abnormal emotional eating, and abnormal resting energy expenditure. We hypothesize that obesity-related phenotypes may predict weight loss to an Individualized Lifestyle intervention based on a tailored Mayo Clinic Diet program. This session will introduce preliminary data using a tailored Mayo Clinic Diet program and phenotypic guided lifestyle interventions to enhance obesity treatment outcomes.

Learning Objectives

1. Describe the heterogeneity of obesity
2. Identify proposed obesity phenotype classifications 
3. Discuss preliminary outcomes of a phenotype-guided lifestyle intervention 

Speakers

Eric Westman, MD, MHS, MFOMA

Justin Tondt, MD

Description

This session will explore the current scientific evidence both for and against the CIM to prepare participants to critically evaluate this and other models of obesity.

Learning Objectives

1. Summarize the current evidence for the carbohydrate-insulin model of obesity.
2. Summarize the current evidence against the carbohydrate-insulin model of obesity. 
3. Compare and contrast the carbohydrate-insulin model of obesity to other models of obesity. 

Speaker

Jennifer Ng, MD, Dipl ABOM

Description

This session will review the benefits of plant-based diets in obesity management and how to incorporate plant-based diets into your practice.  During the presentation, Dr. Ng will go over the evidence supporting plant-based diets in obesity management as well as important nutritional aspects of plant-based diets to counsel your patient on and how to start/overcome barriers for your patients on plant-based diets.  

Learning Objectives

1. Understand how plant-based diets can benefit obesity management
2. Discuss how to get started integrating a plant-based diet into medical practice 
3. Learn how to work with patients to motivate them to utilize a plant-based diet to improve the quality of their nutrition 

Speakers

Eric Westman, MD, MHS, MFOMA

Justin Tondt, MD

Andres Acosta, MD, PhD

Learning Objectives

1. Discuss key takeaways from the nutrition lectures
2. Ask specific questions about managing obesity with the use of nutrition in a Q&A panel with faculty experts. 

Need dinner plans? Sign up to attend a vendor sponsored dine-around on Saturday night! Dinner reservations at the best restaurants near the hotel have been made, so you can spend a stress-free evening out getting to know your colleagues and learning from our vendors. (Dinner costs are covered by the vendor. Advance sign-up required in the mobile app.)

Speaker

Faith Newsome, BA

Description

In this session, Faith Newsome will describe her experiences living with obesity, which eventually culminated in her decision to undergo bariatric surgery at 16. Throughout the session, Newsome will bring to life the data and statistics that those working in obesity know well by telling personal stories. Newsome will also identify opportunities for patient-centered care, and for patients to participate in the research process. 

Learning Objectives

1. Describe the lived experiences of pediatric patients living with obesity
2. Identify opportunities to practice-patient centered care 
3. Identify opportunities for collaboration with patients in the research process 

Speaker

Jeff Sicat, MD, FACE, FOMA

Description

Our patients frequently ask if they should take CBD to assist with weight loss. This presentation will review the role of the endocannabinoid system (ECS) in weight management and discuss the current science and data regarding the impact of CBD and CBD derivatives on obesity, insulin resistance, and metabolic disease.

Learning Objectives

1. Explain the physiology of the endocannabinoid system and how it affects metabolic features
2. Describe the scientific studies of CBD and derivatives impacting obesity and the metabolic system 
3. Formulate thoughts on whether CBD may be an intervention for metabolic disease 

Speaker

Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

Description

The Obesity Medicine Association (OMA) is a science leader regarding clinical obesity medicine. OMA has published several Clinical Practice Statements via its journal - Obesity Pillars. The intent of these CPS is to help clinicians manage patients with obesity. This session will provide a brief overview of some of the more recent OMA Clinical Practice Statements.

Learning Objectives

1. Describe the basic concepts regarding Clinical Practice Statements (CPS) published by the Obesity Medicine Association OMA
2. Identify contents location of OMA CPS. 
3. Utilize the resources provided by CPS and the Obesity Pillars 

Speaker

Daniela Hurtado Andrade, MD, PhD

Description

The treatment approaches to obesity care often give little regard to gender specific needs in weight management.  Nutritional, behavioral, and physical activity treatments vary widely between gender across the lifespan. This presentation will highlight key differences in the pathophysiology of obesity between men and women and how those difference impact obesity treatment. 

Learning Objectives

1. Identify the pathophysiologic differences of obesity in men and women
2. Consider gender specific metabolic and psychologic needs across the lifespan 
3. Describe the limitations of obesity research in men and women 
4. Utilize gender specific therapies for obesity 

Speaker

Karen Herbst, MD, PhD

Description

One of the limitations of BMI is that it fails to account for either body composition or body fat distribution. While patients with lipedema may have a BMI >30kg/m2, their condition is very different from most obesity associated with positive energy balance. Accumulation of fibroadipose tissue in the lower body and arms has distinct pathologic features as well as resistance to conventional therapies. This session will examine how lipedema is different from most forms of obesity, how it is diagnosed, and the unique treatment strategies used to combat this challenging condition.

Learning Objectives

1. Define lipedema and distinguish it from other adiposity-related disorders 
2. Discuss the Standards of Care for Lipedema in the US 
3. Describe the role of supplements, nutrition, manual therapy, and surgery in lipedema treatment 
4. Utilize effective treatment strategies for patients with lipedema